All Stories

  1. Safety and Efficacy of Teplizumab for Treatment of Type One Diabetes Mellitus: A Systematic Review and Meta-Analysis

    Article • Endocrine Metabolic & Immune Disorders - Drug Targets, October 2021, Bentham Science Publishers

    Ammar Ismail, Mohamed Zaazouee, Anira Yasmine Benmelouka